Fig 5. Prevalence of SARS-CoV-2 antibodies in the participating population.
A) Partitioned by occupation. B) Partitioned by workstation.C) Partitioned by age group. D) Partitioned by self-reported co-morbidities. E) Partitioned by self-reported COVID-19-like symptoms and work station within the past 4 months. F) Partitioned by self-reported COVID-19-like symptoms during the study period.